We are live on ! Find out more
PACB icon

Pacific Biosciences
PACB

71 hedge funds and large institutions have $74.4M invested in Pacific Biosciences in 2013 Q2 according to their latest regulatory filings, with 71 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more call options, than puts

Call options by funds: $50K | Put options by funds: $15K

Holders
71
Holders Change
+71
Holders Change %
–
% of All Funds
2.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
71
Increased
–
Reduced
–
Closed
–
Calls
$50K
Puts
$15K
Net Calls
+$35K
Net Calls Change
+$35K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PACB Hedge Fund Activity: Q2 2013 in Review

71 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Pacific Biosciences (PACB) for Q2 2013, worth a combined $74.4M.

Buyers outnumbered sellers: 71 funds opened new PACB positions and 0 closed out — a net gain of 71 holders — while 0 added to existing stakes and 0 trimmed.

  • 71 institutional investors held Pacific Biosciences (PACB) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $74.4M of Pacific Biosciences stock for Q2 2013.
  • 71 funds opened new Pacific Biosciences positions in Q2 2013 and 0 closed out, a net change of +71 holders.

Based on aggregated 13F filings for Q2 2013.